Tianjin Tianyao Pharmaceuticals Co Ltd (600488) — Financial Flexibility Index
Tianjin Tianyao Pharmaceuticals Co Ltd (600488) has a Financial Flexibility Index of 0.02x as of September 2025. Free cash flow of CN¥30.67 Million (operating CF CN¥13.19 Million minus capex CN¥17.49 Million) represents 0% of total liabilities (CN¥1.85 Billion). Check Tianjin Tianyao Pharmaceuticals Co Ltd (600488) total reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Tianjin Tianyao Pharmaceuticals Co Ltd Financial Flexibility Index (2000–2024)
Historical Financial Flexibility Index trend for Tianjin Tianyao Pharmaceuticals Co Ltd across 25 annual periods. For the full cash flow conversion analysis, see Tianjin Tianyao Pharmaceuticals Co Ltd operating cash flow efficiency.
Annual Financial Flexibility Index for Tianjin Tianyao Pharmaceuticals Co Ltd (2000–2024)
Year-by-year free cash flow to debt coverage for Tianjin Tianyao Pharmaceuticals Co Ltd. Explore Tianjin Tianyao Pharmaceuticals Co Ltd (600488) debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.36x | CN¥647.11 Million | CN¥569.37 Million | CN¥1.81 Billion | ▼ -6.9% |
| 2023 | 0.38x | CN¥916.16 Million | CN¥783.01 Million | CN¥2.39 Billion | ▲ +29.8% |
| 2022 | 0.30x | CN¥855.72 Million | CN¥653.52 Million | CN¥2.90 Billion | ▲ +8.6% |
| 2021 | 0.27x | CN¥687.73 Million | CN¥316.89 Million | CN¥2.53 Billion | ▼ -18.8% |
| 2020 | 0.34x | CN¥805.40 Million | CN¥346.88 Million | CN¥2.40 Billion | ▲ +1.7% |
| 2019 | 0.33x | CN¥558.41 Million | CN¥279.37 Million | CN¥1.70 Billion | ▲ +27.3% |
| 2018 | 0.26x | CN¥392.85 Million | CN¥189.27 Million | CN¥1.52 Billion | ▲ +165.5% |
| 2017 | 0.10x | CN¥112.45 Million | CN¥-8.15 Million | CN¥1.15 Billion | ▼ -61.1% |
| 2016 | 0.25x | CN¥128.10 Million | CN¥63.32 Million | CN¥511.21 Million | ▼ -16.2% |
| 2015 | 0.30x | CN¥174.83 Million | CN¥129.50 Million | CN¥584.42 Million | ▼ -23.3% |
| 2014 | 0.39x | CN¥195.54 Million | CN¥178.76 Million | CN¥501.34 Million | ▼ -22.3% |
| 2013 | 0.50x | CN¥394.63 Million | CN¥84.55 Million | CN¥785.64 Million | ▲ +309.5% |
| 2012 | 0.12x | CN¥88.82 Million | CN¥13.23 Million | CN¥724.13 Million | ▼ -36.6% |
| 2011 | 0.19x | CN¥141.24 Million | CN¥78.47 Million | CN¥729.86 Million | ▼ -5.8% |
| 2010 | 0.21x | CN¥264.58 Million | CN¥116.82 Million | CN¥1.29 Billion | ▼ -65.6% |
| 2009 | 0.60x | CN¥637.45 Million | CN¥435.13 Million | CN¥1.07 Billion | ▲ +10.5% |
| 2008 | 0.54x | CN¥576.94 Million | CN¥219.31 Million | CN¥1.07 Billion | ▲ +19.3% |
| 2007 | 0.45x | CN¥387.07 Million | CN¥162.33 Million | CN¥854.65 Million | ▲ +401.9% |
| 2006 | 0.09x | CN¥121.63 Million | CN¥50.72 Million | CN¥1.35 Billion | ▲ +78.0% |
| 2005 | 0.05x | CN¥47.32 Million | CN¥-108.87 Million | CN¥933.43 Million | ▼ -88.7% |
| 2004 | 0.45x | CN¥243.77 Million | CN¥110.30 Million | CN¥541.10 Million | ▲ +37.0% |
| 2003 | 0.33x | CN¥220.01 Million | CN¥45.77 Million | CN¥669.25 Million | ▼ -3.6% |
| 2002 | 0.34x | CN¥216.48 Million | CN¥45.28 Million | CN¥634.50 Million | ▲ +18.8% |
| 2001 | 0.29x | CN¥120.44 Million | CN¥71.87 Million | CN¥419.39 Million | ▲ +8.1% |
| 2000 | 0.27x | CN¥77.35 Million | CN¥41.06 Million | CN¥291.03 Million | — |